Literature DB >> 2300249

Botulinum toxin injections for cervical dystonia.

J Jankovic1, K Schwartz.   

Abstract

We followed 205 of 232 patients with medically intractable cervical dystonia for at least 3 months and up to 4 years, during which time they received 1,074 injections in 505 visits. One hundred forty-five of the 205 patients (71%) improved substantially (global rating greater than or equal to 2; from 0 = no response to 4 = marked improvement in severity and function) after 1 or more visits. Of the 89 patients who reported pain, 68 (76%) had almost complete relief of their pain. While most patients noted improvement within the 1st week after injection, some had a latency of up to 8.5 weeks. Duration of maximum benefit lasted up to 12.5 months in some, but the average was 11.2 weeks. Only 58 of 205 (28%) patients, seen in 76 of 505 visits (15% of all visits), had complications, primarily mild dysphagia (35 patients) or neck weakness (17 patients). We conclude that botulinum toxin is a safe and effective therapy for most patients with cervical dystonia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2300249     DOI: 10.1212/wnl.40.2.277

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  40 in total

1.  Pallidal deep brain stimulation in patients with cervical dystonia and severe cervical dyskinesias with cervical myelopathy.

Authors:  J K Krauss; T J Loher; T Pohle; S Weber; E Taub; C B Bärlocher; J-M Burgunder
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

2.  Mechanism of Botulinum Toxin in the Relief of Chronic Pain.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

Review 3.  New approaches in the treatment of the dystonias.

Authors:  N Diederich; C G Goetz; C L Comella
Journal:  Klin Wochenschr       Date:  1990-10-03

4.  Cervical Dystonia (Torticollis).

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

5.  Treatment of spasmodic torticollis with local injections of botulinum toxin. One-year follow-up in 37 patients.

Authors:  W Poewe; L Schelosky; B Kleedorfer; F Heinen; M Wagner; G Deuschl
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

6.  Evolution of dose and response to botulinum toxin A in cervical dystonia: a multicenter study.

Authors:  Pedro J Garcia Ruiz; Juan Carlos Martínez Castrillo; Juan A Burguera; Victor Campos; Alfonso Castro; Esther Cancho; Jose Chacón; Jaime Hernández Vara; Javier Lopez del Val; Elena Lopez Garcia; Francesc Miquel; Pilar Sanz; Lydia Vela
Journal:  J Neurol       Date:  2011-01-01       Impact factor: 4.849

Review 7.  Treatment of chronic low back pain with botulinum neurotoxins.

Authors:  Bahman Jabbari
Journal:  Curr Pain Headache Rep       Date:  2007-10

Review 8.  Evidence based medicine in the use of botulinum toxin for back pain.

Authors:  B Jabbari
Journal:  J Neural Transm (Vienna)       Date:  2008-03-25       Impact factor: 3.575

9.  Injecting under pressure: the pain of low CSF pressure headache responsive to botulinum toxin injections.

Authors:  Paul G Mathew; F Michael Cutrer
Journal:  Curr Neurol Neurosci Rep       Date:  2014-09       Impact factor: 5.081

10.  The Use of Botulinum Toxin Type A in Headache Treatment.

Authors:  Ninan T. Mathew; Alex O. Kaup
Journal:  Curr Treat Options Neurol       Date:  2002-09       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.